Company: ABUS
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012305
Chunk: 37

Company: Arbutus Biopharma Corp
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 37
---
9) | As reported on Schedule 13G/A filed with the SEC on February 3, 2025 by Morgan Stanley and Morgan Stanley Investment Management Inc. The principal business address for each of the reporting persons is 1585 Broadway, New York, NY 10036. |

| (10) | As reported on Schedule 13G/A filed with the SEC on February 21, 2025 by Whitefort Capital Management, LP (“Whitefort Management”), David Salanic, and Joseph Kaplan. Whitefort Management acts as the investment manager of certain client accounts. Each of Mr. Salanic and Mr. Kaplan is a Co-Managing Partner of Whitefort Management. By virtue of these relationships, each of Whitefort Management, Mr. Salanic and Mr. Kaplan may be deemed to have voting and dispositive power with respect to Common Shares held in client accounts managed by Whitefort Management. The principal address for each of the reporting persons is 12 East 49th Street, 40th Floor, New York, NY 10017. |

| (11) | As reported on Schedule 13G/A filed with the SEC on February 12, 2024. The address for the entities affiliated with BlackRock, Inc. is c/o BlackRock, Inc., 50 Hudson Yards, New York, NY 10001. |

23

TABLE OF CONTENTS

EXECUTIVE COMPENSATION Our named executive officers (the “Named Executive Officers”) for the year ended December 31, 2024 were:

| • | Michael J. McElhaugh, our former Interim President and Chief Executive Officer; |

| • | David C. Hastings, our former Chief Financial Officer; |

| • | Karen Sims, M.D., Ph.D., our former Chief Medical Officer; and |

Summary Compensation Table The following table provides information regarding the compensation awarded to, earned by or paid to our Named Executive Officers for the years ended December 31, 2024 and 2023. Dr. Sims was not a Named Executive Officer for the year ended December 31, 2023; accordingly, her compensation for such year is not included in the following table. All amounts are expressed in US dollars. All of the Named Executive Officers included in the table below have departed the Company, and are being included in accordance with SEC rules.

| Name and Principal Position  |      |     | Year |         |     |  Salary 
     ($) |   |     | Bonus 
 ($)   |         |